ScholarIQanswers from OpenAlex

Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin

PaperCitations, authors & open-access status

Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin have?

ScholarIQcitation count

Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin has 68 citations in the OpenAlex counts ScholarIQ stores.

When was Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin published?

ScholarIQyear

Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin has 2011 year in the ScholarIQ index.

Open the OpenAlex record →

What is the open-access status of Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin?

ScholarIQoa status

Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin has closed oa status in the ScholarIQ index.

Open the OpenAlex record →

What is the DOI of Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin?

ScholarIQdoi

The DOI for Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin is on the source record.

Open the DOI →

What is the PMID of Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin?

ScholarIQpmid

The PMID for Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin is on the source record.

Open the PMID →

What is the OpenAlex record for Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin?

ScholarIQopenalex

The OpenAlex for Overcoming Erlotinib Resistance in EGFR Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin is on the source record.

Open the OpenAlex →

Overcoming Erlotinib Resistance in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin

How many citations does Overcoming Erlotinib Resistance in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin have?

When was Overcoming Erlotinib Resistance in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin published?

What is the open-access status of Overcoming Erlotinib Resistance in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin?

What is the DOI of Overcoming Erlotinib Resistance in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin?

What is the PMID of Overcoming Erlotinib Resistance in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin?

What is the OpenAlex record for Overcoming Erlotinib Resistance in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer Cells by Targeting Survivin?

Related on ScholarIQ